InterOcean Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$612K Hold
7,952
0.05% 104
2020
Q1
$594K Sell
7,952
-500
-6% -$34.5K 0.05% 108
2019
Q4
$549K Buy
8,452
+2
+0% +$130 0.04% 128
2019
Q3
$536K Hold
8,450
0.04% 132
2019
Q2
$571K Sell
8,450
-622
-7% -$40.9K 0.05% 121
2019
Q1
$590K Sell
9,072
-26
-0.3% -$1.73K 0.05% 116
2018
Q4
$569K Sell
9,098
-474
-5% -$33.1K 0.06% 123
2018
Q3
$739K Sell
9,572
-81
-0.8% -$6.12K 0.08% 115
2018
Q2
$684K Buy
+9,653
New +$682K 0.08% 115

Other funds holding GILD

InterOcean Capital's GILD Position: Q2 2020 in Review

InterOcean Capital held its Gilead Sciences (GILD) position steady in Q2 2020 at 7,952 shares worth $612K. The position accounts for 0.05% of the portfolio, ranked #104.

InterOcean Capital first reported a position in GILD in Q2 2018 and has held it in 9 quarters since. The position peaked at $739K in Q3 2018. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • InterOcean Capital held 7,952 shares of Gilead Sciences worth $612K as of Q2 2020.
  • InterOcean Capital left its Gilead Sciences share count unchanged in Q2 2020.
  • Gilead Sciences made up 0.05% of InterOcean Capital's portfolio in Q2 2020, its #104 holding.
  • InterOcean Capital first reported a position in Gilead Sciences in Q2 2018 and has held it in 9 quarters since.
  • InterOcean Capital's Gilead Sciences position peaked at $739K in Q3 2018.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on InterOcean Capital's 13F filing for Q2 2020, filed 13 Aug 2020.